{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:23:38Z","timestamp":1775546618431,"version":"3.50.1"},"reference-count":41,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"abstract":"\n OBJECTIVE:<\/jats:title>\n The aim of this study was to uncover the most effective and safe criterion to implement for retinopathy of prematurity screening in Denmark.<\/jats:p>\n <\/jats:sec>\n \n METHODS:<\/jats:title>\n This retrospective national cohort study is based on data from 3 national registers. These registers provided on infants treated for retinopathy of prematurity, infants in need of treatment but missed by the present screening program, and the candidate neonates for advanced retinopathy of prematurity development A nonlinear logistic regression model was fitted to the data, and various screening criteria were evaluated.<\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n During the study period (2002\u20132006), 116 infants were treated for retinopathy of prematurity, no treatment-demanding retinopathy of prematurity infants were missed by the screening program, and 182 premature infants were candidates for developing treatment-demanding retinopathy of prematurity. Screening criteria combining gestational age at delivery and birth weight limits and new risk-based criteria were compared with regards to their effectiveness. The risk-based criteria were the most effective. Use of the 0.13% risk-based criterion to define the population to be screened resulted in the detection of all treated infants in the study period and 17.4% fewer infants to screen. The model predicted this criterion to result in 1 missed case of treatment-demanding retinopathy of prematurity every 11 years and 1 case of blindness every 18 years in Denmark.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS:<\/jats:title>\n Screening criteria based on risk estimates of developing treatment-demanding retinopathy of prematurity are the most effective for retinopathy-of-prematurity screening. The risk-based criterion of 0.13% can safely be implemented for future retinopathy-of-prematurity screening in Denmark.<\/jats:p>\n <\/jats:sec>","DOI":"10.1542\/peds.2010-1974","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T09:55:10Z","timestamp":1297763710000},"page":"e598-e606","source":"Crossref","is-referenced-by-count":18,"title":["A New Risk-Based Screening Criterion for Treatment-Demanding Retinopathy of Prematurity in Denmark"],"prefix":"10.1542","volume":"127","author":[{"given":"Carina","family":"Slidsborg","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie Lyng","family":"Forman","sequence":"additional","affiliation":[{"name":"Departmant of Biostatistics, University of Copenhagen, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"National Board of Health, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark;"},{"name":"Eye Clinic, Kennedy Center, Glostrup, Denmark; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamilla Rothe","family":"Nissen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Koch","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regitze","family":"Bangsgaard","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Call\u00f8","family":"Fledelius","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorm","family":"Greisen","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Copenhagen University Hospital, Rigshospitalet, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"la Cour","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Copenhagen University Hospital, Glostrup Hospital, Copenhagen, Denmark;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"issue":"8","key":"2021121007031047000_B1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/S0161-6420(03)00498-6","article-title":"Visual impairment in children born prematurely from 1972 through 1989","volume":"110","author":"Rudanko","year":"2003","journal-title":"Ophthalmology"},{"issue":"11","key":"2021121007031047000_B2","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/archopht.122.11.1659","article-title":"Health-related quality of life at age 10 years in very low-birth-weight children with and without threshold retinopathy of prematurity","volume":"122","author":"Quinn","year":"2004","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"2021121007031047000_B3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1542\/peds.81.5.697","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results","volume":"81","author":"Cryotherapy for Retinopathy of Prematurity Cooperative Group","year":"1988","journal-title":"Pediatrics"},{"issue":"3","key":"2021121007031047000_B4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000079542","article-title":"Screening for retinopathy of prematurity: is it painful","volume":"86","author":"Belda","year":"2004","journal-title":"Biol Neonate"},{"issue":"5","key":"2021121007031047000_B5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/bjo.80.5.425","article-title":"Systemic effects of screening for retinopathy of prematurity","volume":"80","author":"Laws","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"2021121007031047000_B6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1440-1754.2003.00144.x","article-title":"Transient paralytic ileus following the use of cyclopentolate-phenylephrine eye drops during screening for retinopathy of prematurity","volume":"39","author":"Lim","year":"2003","journal-title":"J Paediatr Child Health"},{"issue":"6","key":"2021121007031047000_B7","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/bjo.2006.092361","article-title":"Retinal haemorrhages in a preterm infant following screening examination for retinopathy of prematurity","volume":"90","author":"Lim","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"2021121007031047000_B8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/112067219600600218","article-title":"Effects and side effects of mydriatic eyedrops in neonates","volume":"6","author":"Ogut","year":"1996","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"2021121007031047000_B9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1651-2227.2009.01612.x","article-title":"Pain management during eye examinations for retinopathy of prematurity in preterm infants: a systematic review","volume":"99","author":"Sun","year":"2010","journal-title":"Acta Paediatr"},{"issue":"6","key":"2021121007031047000_B10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaapos.2005.07.007","article-title":"Retinopathy of prematurity: an optimum screening strategy","volume":"9","author":"Ho","year":"2005","journal-title":"J AAPOS"},{"issue":"5","key":"2021121007031047000_B11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/sj.eye.6700031","article-title":"Retinopathy of prematurity: are we screening too many babies","volume":"16","author":"Mathew","year":"2002","journal-title":"Eye (Lond)"},{"issue":"1 pt 1","key":"2021121007031047000_B12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1542\/peds.102.1.31","article-title":"Should fewer premature infants be screened for retinopathy of prematurity in the managed care era","volume":"102","author":"Wright","year":"1998","journal-title":"Pediatrics"},{"issue":"pt 4","key":"2021121007031047000_B13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/eye.1997.136","article-title":"Are we screening too many babies for retinopathy of prematurity","volume":"11","author":"Goble","year":"1997","journal-title":"Eye (Lond)"},{"issue":"2","key":"2021121007031047000_B14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/112067219600600216","article-title":"Retinopathy of prematurity in Denmark: epidemiological considerations and screening limits","volume":"6","author":"Fledelius","year":"1996","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"2021121007031047000_B15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1034\/j.1600-0420.2000.078003359.x","article-title":"Retinopathy of prematurity, a decrease in frequency and severity: trends over 16 years in a Danish county","volume":"78","author":"Fledelius","year":"2000","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"2021121007031047000_B16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1600-0420.2003.00199.x","article-title":"Surveillance for retinopathy of prematurity in a Danish country: epidemiological experience over 20 years","volume":"82","author":"Fledelius","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"2021121007031047000_B17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1542\/peds.2007-0644","article-title":"Treatment for retinopathy of prematurity in Denmark in a ten-year period (1996 2005): is the incidence increasing","volume":"121","author":"Slidsborg","year":"2008","journal-title":"Pediatrics"},{"issue":"12","key":"2021121007031047000_B18","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.121.12.1684","article-title":"Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial","volume":"121","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"2021121007031047000_B19","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1651-2227.1996.tb14164.x","article-title":"Intrauterine growth curves based on ultrasonically estimated foetal weights","volume":"85","author":"Mars\u00e1l","year":"1996","journal-title":"Acta Paediatr"},{"issue":"10","key":"2021121007031047000_B20","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1651-2227.1990.tb11351.x","article-title":"Retinopathy of prematurity: where to set screening limits? Recommendations based on two Danish surveys","volume":"79","author":"Fledelius","year":"1990","journal-title":"Acta Paediatr Scand"},{"issue":"3","key":"2021121007031047000_B21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archopht.123.3.311","article-title":"15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity","volume":"123","author":"Palmer","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"2021121007031047000_B22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"2021121007031047000_B23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0895-4356(91)90146-Z","article-title":"Assessing predictive accuracy: how to compare Brier score","volume":"44","author":"Redelmeier","year":"1991","journal-title":"J Clin Epidemiol"},{"key":"2021121007031047000_B24","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511802843","volume-title":"Bootstrap Methods and Their Application","author":"Davison","year":"1997"},{"key":"2021121007031047000_B25","unstructured":"R Development Core Team. R: A Language and Environment for Statistical Computing\u2008[computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2008. Available at: www.R-project.org."},{"issue":"3","key":"2021121007031047000_B26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archpedi.155.3.387","article-title":"Evidence for changing guidelines for routine screening for retinopathy of prematurity","volume":"155","author":"Lee","year":"2001","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"2021121007031047000_B27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.eye.6700296","article-title":"Retinopathy of prematurity in practice. I: screening for threshold disease","volume":"17","author":"Brennan","year":"2003","journal-title":"Eye (Lond)"},{"issue":"2","key":"2021121007031047000_B28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaapos.2005.08.005","article-title":"Retinopathy of prematurity in infants with birth weight > or = 1250 grams-incidence, severity, and screening guideline cost-analysis","volume":"10","author":"Yanovitch","year":"2006","journal-title":"J AAPOS"},{"issue":"2","key":"2021121007031047000_B29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/sj.eye.6701437","article-title":"Severe retinopathy of prematurity: longitudinal observation of disease and screening implications","volume":"19","author":"Ells","year":"2005","journal-title":"Eye (Lond)"},{"issue":"3","key":"2021121007031047000_B30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0420.1997.tb00780.x","article-title":"Incidence of retinopathy of prematurity (ROP) in the western part of Norway: a population-based retrospective study","volume":"75","author":"Haugen","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"issue":"12","key":"2021121007031047000_B31","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1136\/bjo.86.12.1399","article-title":"Screening for retinopathy of prematurity: evaluation and modification of guidelines","volume":"86","author":"Larsson","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2021121007031047000_B32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0420.1997.tb00254.x","article-title":"Retinopathy of prematurity: the continuing threat to vision in preterm infants. Dutch survey from 1986 to 1994","volume":"75","author":"Schalij-Delfos","year":"1997","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"2021121007031047000_B33","first-page":"572","article-title":"Screening examination of premature infants for retinopathy of prematurity [published correction appears in Pediatrics. 2006;118(3):1324]","volume":"117","author":"Section on Ophthalmology, American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology, Strabismus","year":"2006","journal-title":"Pediatrics"},{"issue":"11","key":"2021121007031047000_B34","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/eye.2008.128","article-title":"UK retinopathy of prematurity guideline","volume":"23","author":"Wilkinson","year":"2009","journal-title":"Eye (Lond)"},{"issue":"11","key":"2021121007031047000_B35","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0161-6420(91)32074-8","article-title":"Incidence and early course of retinopathy of prematurity: the Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"98","author":"Palmer","year":"1991","journal-title":"Ophthalmology"},{"issue":"2","key":"2021121007031047000_B36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000085295","article-title":"Can screening for retinopathy of prematurity be reduced","volume":"88","author":"Termote","year":"2005","journal-title":"Biol Neonate"},{"issue":"4","key":"2021121007031047000_B37","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-2697","article-title":"Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening","volume":"123","author":"Hellstr\u00f6m","year":"2009","journal-title":"Pediatrics"},{"key":"2021121007031047000_B38","article-title":"Prematuren retinopathie, richtlijn voor screening","author":"Schalij-Delfor","year":"1999","journal-title":"Richtlijn oogheelkunde. Deventer, Uitgave Commissie Kwaliteit van het Nederlands Oogheelkundig Gezelschap"},{"issue":"5","key":"2021121007031047000_B39","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2004-1180","article-title":"Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs","volume":"115","author":"Gilbert","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"2021121007031047000_B40","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00417-009-1248-6","article-title":"The influence of gestational age on the dynamic behavior of other risk factors associated with retinopathy of prematurity (ROP)","volume":"248","author":"Fortes Filho","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9\u201310","key":"2021121007031047000_B41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/1120672103013009-1009","article-title":"Retinopathy of prematurity: any difference in risk factors between a high and low risk population","volume":"13","author":"Allegaert","year":"2003","journal-title":"Eur J Ophthalmol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/3\/e598\/907714\/zpe0031100e598.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/127\/3\/e598\/907714\/zpe0031100e598.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T16:20:09Z","timestamp":1639153209000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/127\/3\/e598\/65063\/A-New-Risk-Based-Screening-Criterion-for-Treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,1]]},"published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2010-1974","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}